Related Experiment Videos
Substance P modulation of the mesolimbic dopamine system
Progress in Clinical and Biological Research
|January 1, 1985
Summary
Microinjections of substance P into specific brain regions of rats increased locomotor activity. However, dopamine metabolite increases in the nucleus accumbens only occurred with injections into certain nuclei, suggesting localized effects.
Area of Science:
- Neuroscience
- Neuropharmacology
- Behavioral Neuroscience
Background:
- Previous research indicates substance P in the ventral tegmental area increases locomotor activity via the mesolimbic dopamine system.
- The precise subregions within the ventromedial mesencephalon mediating this effect require further elucidation.
Purpose of the Study:
- To investigate the effects of substance P microinjections into specific subnuclei of the ventromedial mesencephalon on locomotor activity.
- To determine the impact of these microinjections on dopamine and its metabolites in the nucleus accumbens.
Main Methods:
- Rats received microinjections of substance P into various subnuclei of the ventromedial mesencephalon.
- Locomotor activity was measured following injections.
- Levels of dopamine and its metabolites were quantified in the nucleus accumbens post-injection.
Main Results:
- Microinjections into all tested nuclei within the A-10 dopamine region resulted in increased motor activity.
- Elevated dopamine metabolites in the nucleus accumbens were observed exclusively after injections into the nucleus paranigralis and nucleus parabrachialis pigmentosus.
- Injections into the nucleus linearis and nucleus interfascicularis did not alter dopamine metabolite levels in the nucleus accumbens.
Conclusions:
- Substance P administration into the A-10 dopamine region broadly enhances motor activity.
- Specific nuclei within the ventromedial mesencephalon, namely the nucleus paranigralis and nucleus parabrachialis pigmentosus, are critical for substance P-induced increases in nucleus accumbens dopamine metabolites.
- These findings highlight the differential neurochemical consequences of substance P actions within the mesolimbic dopamine system.